CD274 and non-small cell lung carcinoma: Published studies have consistently reported wide ranges of the rate of PD-L1 expressing CTCs, from 8 to 100%, in NSCLC (Acheampong et al. 2020; Kong et al. 2021; Ouyang et al. 2021).